Literature DB >> 19415334

Comparison of distinct protein isoforms of the receptor for advanced glycation end-products expressed in murine tissues and cell lines.

Julia V Gefter1, Angel L Shaufl, Mitchell P Fink, Russell L Delude.   

Abstract

The receptor for advanced glycation end-products (RAGE) is thought to be expressed ubiquitously as various protein isoforms. Our objective was to use Northern blotting, immunoblotting, and sensitivity to N-glycanase digestion to survey RAGE isoforms expressed in cell lines and mouse tissues in order to obtain a more comprehensive view of the RAGE expressome. Pulmonary RAGE mRNA (1.4 kb) was smaller than cell-line and tissue RAGE mRNA (6 kb-10 kb). Three anti-RAGE antibodies that recognized three distinct RAGE epitopes were used for protein studies (N-16, H-300, and alphaES). Lung expressed three predominant protein isoforms with apparent molecular masses of 45.1, 52.6, and 57.4 kDa (N-16/H-300) and four isoforms at 25.0, 46.9, 52.5, and 54.2 kDa (alphaES). These isoforms were expressed exclusively in lung. Heart, ileum, and kidney expressed a 44.0-kDa isoform (N-16), whereas aorta and pancreas expressed a 53.3-kDa isoform (alphaES). Each of these isoforms were absent in tissue extracts prepared from RAGE(-/-) mice. Cell lines expressed a 70.0-kDa isoform, and a subset expressed a 30.0-kDa isoform (alphaES). Lung RAGE appeared to contain two N-linked glycans. Tissue and cell-line RAGE isoforms were completely insensitive to PNGase F digestion. Thus, numerous RAGE protein isoforms are detectable in tissues and cell lines. Canonical transmembrane and soluble RAGE appear to be expressed solely in lung (N-16/H-300). Non-pulmonary tissues and cell lines, regardless of the source tissue, both express distinct RAGE protein isoforms containing the N-terminal N-16 epitope or the alphaES RAGE epitope encoded by alternate exon 9, but lacking the H-300 epitope.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19415334     DOI: 10.1007/s00441-009-0791-0

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  14 in total

Review 1.  The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome.

Authors:  Weidun Alan Guo; Paul R Knight; Krishnan Raghavendran
Journal:  Intensive Care Med       Date:  2012-07-10       Impact factor: 17.440

2.  The receptor for advanced glycation end products mediates lung endothelial activation by RBCs.

Authors:  Nilam S Mangalmurti; Jessica L Friedman; Liang-Chuan Wang; Donna Stolz; Geetha Muthukumaran; Don L Siegel; Ann Marie Schmidt; Janet S Lee; Steven M Albelda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-12-28       Impact factor: 5.464

Review 3.  All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.

Authors:  Elizabeth A Oczypok; Timothy N Perkins; Tim D Oury
Journal:  Paediatr Respir Rev       Date:  2017-03-18       Impact factor: 2.726

4.  The role of the receptor for advanced glycation end-products in a murine model of silicosis.

Authors:  Lasse Ramsgaard; Judson M Englert; Jacob Tobolewski; Lauren Tomai; Cheryl L Fattman; Adriana S Leme; A Murat Kaynar; Steven D Shapiro; Jan J Enghild; Tim D Oury
Journal:  PLoS One       Date:  2010-03-19       Impact factor: 3.240

Review 5.  The receptor for advanced glycation end products (RAGE) and the lung.

Authors:  Stephen T Buckley; Carsten Ehrhardt
Journal:  J Biomed Biotechnol       Date:  2010-01-19

6.  The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics.

Authors:  R Kang; D Tang; N E Schapiro; T Loux; K M Livesey; T R Billiar; H Wang; B Van Houten; M T Lotze; H J Zeh
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

7.  The receptor for advanced glycation end products is a central mediator of asthma pathogenesis.

Authors:  Pavle S Milutinovic; John F Alcorn; Judson M Englert; Lauren T Crum; Tim D Oury
Journal:  Am J Pathol       Date:  2012-08-11       Impact factor: 4.307

8.  Impact of hyperglycemia and acute pancreatitis on the receptor for advanced glycation endproducts.

Authors:  Dietmar Zechner; Kai Sempert; Berit Genz; Franziska Timm; Florian Bürtin; Tim Kroemer; Antje Butschkau; Angela Kuhla; Brigitte Vollmar
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15

9.  Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in mice.

Authors:  Lasse Ramsgaard; Judson M Englert; Michelle L Manni; Pavle S Milutinovic; Julia Gefter; Jacob Tobolewski; Lauren Crum; Gina M Coudriet; Jon Piganelli; Ruben Zamora; Yoram Vodovotz; Jan J Enghild; Tim D Oury
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

Review 10.  The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target?

Authors:  Benedict C Creagh-Brown; Gregory J Quinlan; Timothy W Evans; Anne Burke-Gaffney
Journal:  Intensive Care Med       Date:  2010-07-15       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.